UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Nektar Therapeutics is implementing good security practices.
Nektar Therapeutics (Nektar) is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances.
This report shows a preliminary security rating for Nektar Therapeutics. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
Each year brings new cybersecurity threats, data breaches, attack vectors, and previously unknown ...
A data leak is when sensitive data is accidentally exposed physically, on the Internet or any other ...
Compare Nektar Therapeutics's security performance with other companies